Genetronics Biomedical LTD Sample Contracts

AutoNDA by SimpleDocs
WITNESSETH
Asset Purchase Agreement • July 30th, 2002 • Genetronics Biomedical Corp • Surgical & medical instruments & apparatus
PREAMBLE
License Agreement • November 9th, 2000 • Genetronics Biomedical LTD • Surgical & medical instruments & apparatus • Florida
INOVIO PHARMACEUTICALS, INC. (a Delaware corporation) 17,700,000 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • January 22nd, 2021 • Inovio Pharmaceuticals, Inc. • Surgical & medical instruments & apparatus • New York
SUPPLY AGREEMENT
Supply Agreement • August 10th, 2000 • Genetronics Biomedical LTD • Surgical & medical instruments & apparatus
RECITAL:
Stock Purchase Agreement • June 29th, 1999 • Genetronics Biomedical LTD • Surgical & medical instruments & apparatus • New Jersey
INOVIO PHARMACEUTICALS, INC, Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20 Debt Securities
Indenture • November 9th, 2023 • Inovio Pharmaceuticals, Inc. • Surgical & medical instruments & apparatus • New York

INDENTURE, dated as of [•], 20__, among INOVIO PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and[TRUSTEE], as trustee (the “Trustee”):

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • July 30th, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of July 29, 2009, between Inovio Biomedical Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

INOVIO PHARMACEUTICALS, INC. AND , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF
Warrant Agreement • November 9th, 2023 • Inovio Pharmaceuticals, Inc. • Surgical & medical instruments & apparatus • New York

THIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between INOVIO PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).

INOVIO PHARMACEUTICALS, INC. and , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF
Common Stock Warrant Agreement • March 13th, 2020 • Inovio Pharmaceuticals, Inc. • Surgical & medical instruments & apparatus • New York

COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between INOVIO PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).

INOVIO PHARMACEUTICALS, INC. AND _____________, AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF _____________
Warrant Agreement • November 9th, 2023 • Inovio Pharmaceuticals, Inc. • Surgical & medical instruments & apparatus • New York

THIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [•], between INOVIO PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).

INOVIO PHARMACEUTICALS, INC. 27,377,266 Shares of Common Stock and Warrants to Purchase 13,688,633 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • March 7th, 2013 • Inovio Pharmaceuticals, Inc. • Surgical & medical instruments & apparatus • New York
INOVIO PHARMACEUTICALS, INC. SALES AGREEMENT
Sales Agreement • June 1st, 2012 • Inovio Pharmaceuticals, Inc. • Surgical & medical instruments & apparatus • New York

Inovio Pharmaceuticals, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:

INOVIO PHARMACEUTICALS, INC. and , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF
Preferred Stock Warrant Agreement • March 13th, 2020 • Inovio Pharmaceuticals, Inc. • Surgical & medical instruments & apparatus • New York

PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between INOVIO PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).

9,500,000 Shares INOVIO PHARMACEUTICALS, INC. Common Stock PURCHASE AGREEMENT
Purchase Agreement • April 30th, 2015 • Inovio Pharmaceuticals, Inc. • Surgical & medical instruments & apparatus • New York

Inovio Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom Piper Jaffray & Co. and Stifel, Nicolaus & Company, Incorporated are acting as representatives (the “Representatives”), an aggregate of 9,500,000 authorized but unissued shares (the “Firm Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company. The Company has also granted to the several Underwriters an option to purchase up to 1,425,000 additional shares of Common Stock, on the terms and for the purposes set forth in Section 2 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Purchase Agreement (this “Agreement”) are herein collectively called the “Securities.”

AutoNDA by SimpleDocs
BMR-WATERIDGE LP,
Lease • May 10th, 2013 • Inovio Pharmaceuticals, Inc. • Surgical & medical instruments & apparatus

IN WITNESS WHEREOF, Tenant has executed this Acknowledgment of Term Commencement Date and Term Expiration Date as of the date first written above.

INOVIO PHARMACEUTICALS, INC. and U.S. BANK NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of February 19, 2019 6.50% Convertible Senior Notes due 2024
Indenture • February 20th, 2019 • Inovio Pharmaceuticals, Inc. • Surgical & medical instruments & apparatus • New York

INDENTURE, dated as of February 19, 2019, between Inovio Pharmaceuticals, Inc., a Delaware corporation, as issuer (the “Company”), and U.S. Bank National Association, as trustee (the “Trustee”).

INOVIO PHARMACEUTICALS, INC. Common Stock ($0.001 par value per share) AT-THE- MARKET EQUITY OFFERING SALES AGREEMENT
Terms Agreement • April 3rd, 2020 • Inovio Pharmaceuticals, Inc. • Surgical & medical instruments & apparatus • New York

Inovio Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time to or through Stifel, Nicolaus & Company, Incorporated (“Stifel Nicolaus”), as sales agent and/or principal (“Agent”), shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”), on the terms set forth in Section 2 of this At-The-Market Equity Offering Sales Agreement (this “Agreement”); provided, however, that in no event shall the Company issue or sell through the Agent such number of Shares that exceeds the Maximum Amount (as defined in Section 2(f)). The Company agrees that whenever it determines to sell Shares directly to the Agent as principal, it will enter into a separate agreement (each, a “Terms Agreement”) in substantially the form of Annex I hereto, relating to such sale in accordance with Section 3 of this Agreement.

21,130,400 Units INOVIO PHARMACEUTICALS, INC. PLACEMENT AGENT AGREEMENT
Placement Agent Agreement • January 24th, 2011 • Inovio Pharmaceuticals, Inc. • Surgical & medical instruments & apparatus • New York
COMMON STOCK PURCHASE WARRANT To Purchase [ ] Shares of Common Stock of INOVIO BIOMEDICAL CORPORATION
Inovio Biomedical Corp • August 6th, 2007 • Surgical & medical instruments & apparatus • California

THIS IS TO CERTIFY THAT Asia Life Sciences Venture Consulting, Inc., or registered assigns (the “Holder”), is entitled, during the Exercise Period (as hereinafter defined), to purchase from Inovio Biomedical Corporation, a Delaware corporation (the “Company”), the Warrant Stock (as hereinafter defined and subject to adjustment as provided herein), in whole or in part, at a purchase price of $3.00 per share, all on and subject to the terms and conditions hereinafter set forth.

AGREEMENT DEFINITIONS
License and Development Agreement • August 10th, 2000 • Genetronics Biomedical LTD • Surgical & medical instruments & apparatus
INDEMNIFICATION AGREEMENT
Indemnification Agreement • August 19th, 2009 • Inovio Biomedical Corp • Surgical & medical instruments & apparatus • Delaware

This INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into this day of , 2009 (the “Effective Date”) by and between Inovio Biomedical Corporation, a Delaware corporation (the “Company”), and [ ] (the “Indemnitee”).

INVESTOR RIGHTS AGREEMENT
Investor Rights Agreement • June 21st, 2004 • Genetronics Biomedical Corp • Surgical & medical instruments & apparatus • New York

This Agreement is being entered into pursuant to the Preferred Stock and Warrant Purchase Agreement, dated as of the date hereof, by and among the Company and the Purchasers (the "Purchase Agreement").

Time is Money Join Law Insider Premium to draft better contracts faster.